Ironwood Pharmaceuticals reported $117.13M in Gross Profit on Sales for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amarin AMRN:US $ 72.39M 41.46M
Astellas Pharma 4503:JP Y 244955M 26313M
Astrazeneca AZN:US 9.11B 169M
AstraZeneca AZN:LN 8.94B 2.9B
Coherus Biosciences CHRS:US $ 50.74M 10.52M
Emergent Biosolutions EBS:US $ 151.6M 358.7M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Exact Sciences EXAS:US $ 351.87M 2.89M
Halozyme Therapeutics HALO:US $ 101.36M 20.94M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
MacroGenics MGNX:US 11.05M 2.15M
Moderna Inc MRNA:US 5.05B 1.21B
Myriad Genetics MYGN:US $ 115M 4.5M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Takeda 4502:JP Y 564909M 54981M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M
YTE INCY:US $ 696.02M 128.26M